Activity

Activity ID

3749

Expires

March 5, 2022

Format Type

Enduring

CME Credit

0.5

Fee

$30
CME Provider

JAMA

Description

Next-generation sequencing is a catchall term for new, high-throughput technologies that allow rapid sequencing of a full genome. It can be used to sequence a patient’s DNA in diagnosing a genetic disorder or characterizing a cancer, but can also be used to sequence the genome of a pathogenic bacteria, virus, fungi, or parasites. In this JAMA clinical review podcast, we talk with authors Marta Gwinn, MD, MPH, and Gregory L. Armstrong, MD, from the CDC, about how next-generation sequencing of infectious pathogens is being implemented in clinical practice and in public health surveillance for infectious disease.

Disclaimers
1. This activity is accredited by the American Medical Association.
2. This activity is free to AMA members.

Register for this Activity

ABMS Member Board Approvals by Type
More Information
Commercial Support?
No

NOTE: If a Member Board has not deemed this activity for MOC approval as an accredited CME activity, this activity may count toward an ABMS Member Board’s general CME requirement. Please refer directly to your Member Board’s MOC Part II Lifelong Learning and Self-Assessment Program Requirements.

Educational Objectives

To understand the difference between older DNA sequencing technologies and newer next-generation sequencing technologies, and to understand how next-generation sequencing is being implemented in public health and in the clinical practice of infectious disease.

Keywords

Genetics and Genomics, Genomics and Precision Health, Infectious Diseases

Competencies

Medical Knowledge

CME Credit Type

AMA PRA Category 1 Credit

View All Activities by this CME Provider

The information provided on this page is subject to change. Please refer to the CME Provider’s website to confirm the most current information.